Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005730 | nucleolus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A4HN73
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 12 |
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003723 | RNA binding | 4 | 11 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0004386 | helicase activity | 2 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0005524 | ATP binding | 5 | 12 |
GO:0016787 | hydrolase activity | 2 | 12 |
GO:0017076 | purine nucleotide binding | 4 | 12 |
GO:0030554 | adenyl nucleotide binding | 5 | 12 |
GO:0032553 | ribonucleotide binding | 3 | 12 |
GO:0032555 | purine ribonucleotide binding | 4 | 12 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 12 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 12 |
GO:0036094 | small molecule binding | 2 | 12 |
GO:0043167 | ion binding | 2 | 12 |
GO:0043168 | anion binding | 3 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0097367 | carbohydrate derivative binding | 2 | 12 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
GO:0140657 | ATP-dependent activity | 1 | 12 |
GO:1901265 | nucleoside phosphate binding | 3 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 304 | 308 | PF00656 | 0.512 |
CLV_C14_Caspase3-7 | 409 | 413 | PF00656 | 0.433 |
CLV_NRD_NRD_1 | 202 | 204 | PF00675 | 0.254 |
CLV_NRD_NRD_1 | 427 | 429 | PF00675 | 0.527 |
CLV_NRD_NRD_1 | 453 | 455 | PF00675 | 0.546 |
CLV_NRD_NRD_1 | 456 | 458 | PF00675 | 0.547 |
CLV_NRD_NRD_1 | 495 | 497 | PF00675 | 0.417 |
CLV_NRD_NRD_1 | 653 | 655 | PF00675 | 0.690 |
CLV_NRD_NRD_1 | 680 | 682 | PF00675 | 0.587 |
CLV_NRD_NRD_1 | 687 | 689 | PF00675 | 0.586 |
CLV_PCSK_FUR_1 | 454 | 458 | PF00082 | 0.663 |
CLV_PCSK_FUR_1 | 579 | 583 | PF00082 | 0.574 |
CLV_PCSK_KEX2_1 | 196 | 198 | PF00082 | 0.251 |
CLV_PCSK_KEX2_1 | 202 | 204 | PF00082 | 0.251 |
CLV_PCSK_KEX2_1 | 320 | 322 | PF00082 | 0.262 |
CLV_PCSK_KEX2_1 | 330 | 332 | PF00082 | 0.262 |
CLV_PCSK_KEX2_1 | 427 | 429 | PF00082 | 0.495 |
CLV_PCSK_KEX2_1 | 453 | 455 | PF00082 | 0.538 |
CLV_PCSK_KEX2_1 | 456 | 458 | PF00082 | 0.513 |
CLV_PCSK_KEX2_1 | 495 | 497 | PF00082 | 0.379 |
CLV_PCSK_KEX2_1 | 554 | 556 | PF00082 | 0.591 |
CLV_PCSK_KEX2_1 | 581 | 583 | PF00082 | 0.524 |
CLV_PCSK_KEX2_1 | 607 | 609 | PF00082 | 0.637 |
CLV_PCSK_KEX2_1 | 653 | 655 | PF00082 | 0.635 |
CLV_PCSK_KEX2_1 | 98 | 100 | PF00082 | 0.335 |
CLV_PCSK_PC1ET2_1 | 196 | 198 | PF00082 | 0.262 |
CLV_PCSK_PC1ET2_1 | 320 | 322 | PF00082 | 0.262 |
CLV_PCSK_PC1ET2_1 | 330 | 332 | PF00082 | 0.262 |
CLV_PCSK_PC1ET2_1 | 554 | 556 | PF00082 | 0.591 |
CLV_PCSK_PC1ET2_1 | 581 | 583 | PF00082 | 0.563 |
CLV_PCSK_PC1ET2_1 | 607 | 609 | PF00082 | 0.637 |
CLV_PCSK_PC1ET2_1 | 98 | 100 | PF00082 | 0.335 |
CLV_PCSK_PC7_1 | 326 | 332 | PF00082 | 0.309 |
CLV_PCSK_SKI1_1 | 2 | 6 | PF00082 | 0.480 |
CLV_PCSK_SKI1_1 | 326 | 330 | PF00082 | 0.262 |
CLV_PCSK_SKI1_1 | 333 | 337 | PF00082 | 0.262 |
CLV_PCSK_SKI1_1 | 428 | 432 | PF00082 | 0.574 |
CLV_PCSK_SKI1_1 | 525 | 529 | PF00082 | 0.303 |
CLV_PCSK_SKI1_1 | 621 | 625 | PF00082 | 0.605 |
CLV_PCSK_SKI1_1 | 98 | 102 | PF00082 | 0.262 |
DEG_APCC_DBOX_1 | 187 | 195 | PF00400 | 0.537 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.593 |
DOC_CKS1_1 | 147 | 152 | PF01111 | 0.451 |
DOC_CYCLIN_RxL_1 | 422 | 433 | PF00134 | 0.591 |
DOC_CYCLIN_RxL_1 | 96 | 105 | PF00134 | 0.492 |
DOC_MAPK_DCC_7 | 344 | 353 | PF00069 | 0.462 |
DOC_MAPK_gen_1 | 330 | 337 | PF00069 | 0.472 |
DOC_MAPK_gen_1 | 375 | 385 | PF00069 | 0.522 |
DOC_MAPK_gen_1 | 554 | 563 | PF00069 | 0.499 |
DOC_MAPK_gen_1 | 613 | 622 | PF00069 | 0.575 |
DOC_MAPK_HePTP_8 | 341 | 353 | PF00069 | 0.462 |
DOC_MAPK_MEF2A_6 | 224 | 233 | PF00069 | 0.416 |
DOC_MAPK_MEF2A_6 | 344 | 353 | PF00069 | 0.462 |
DOC_MAPK_MEF2A_6 | 554 | 563 | PF00069 | 0.441 |
DOC_PP1_RVXF_1 | 179 | 186 | PF00149 | 0.451 |
DOC_PP1_RVXF_1 | 265 | 272 | PF00149 | 0.462 |
DOC_PP1_RVXF_1 | 97 | 104 | PF00149 | 0.472 |
DOC_PP2B_LxvP_1 | 346 | 349 | PF13499 | 0.451 |
DOC_PP2B_LxvP_1 | 559 | 562 | PF13499 | 0.412 |
DOC_PP2B_LxvP_1 | 82 | 85 | PF13499 | 0.556 |
DOC_PP4_FxxP_1 | 385 | 388 | PF00568 | 0.338 |
DOC_PP4_FxxP_1 | 545 | 548 | PF00568 | 0.303 |
DOC_USP7_MATH_1 | 420 | 424 | PF00917 | 0.349 |
DOC_USP7_MATH_1 | 511 | 515 | PF00917 | 0.315 |
DOC_USP7_UBL2_3 | 196 | 200 | PF12436 | 0.440 |
DOC_USP7_UBL2_3 | 434 | 438 | PF12436 | 0.640 |
DOC_WW_Pin1_4 | 109 | 114 | PF00397 | 0.556 |
DOC_WW_Pin1_4 | 146 | 151 | PF00397 | 0.451 |
DOC_WW_Pin1_4 | 485 | 490 | PF00397 | 0.404 |
LIG_14-3-3_CanoR_1 | 224 | 230 | PF00244 | 0.413 |
LIG_14-3-3_CanoR_1 | 232 | 237 | PF00244 | 0.515 |
LIG_14-3-3_CanoR_1 | 427 | 431 | PF00244 | 0.534 |
LIG_14-3-3_CanoR_1 | 510 | 516 | PF00244 | 0.303 |
LIG_14-3-3_CanoR_1 | 608 | 617 | PF00244 | 0.600 |
LIG_BRCT_BRCA1_1 | 381 | 385 | PF00533 | 0.375 |
LIG_Clathr_ClatBox_1 | 173 | 177 | PF01394 | 0.462 |
LIG_FHA_1 | 210 | 216 | PF00498 | 0.462 |
LIG_FHA_1 | 228 | 234 | PF00498 | 0.477 |
LIG_FHA_1 | 28 | 34 | PF00498 | 0.451 |
LIG_FHA_2 | 3 | 9 | PF00498 | 0.313 |
LIG_FHA_2 | 34 | 40 | PF00498 | 0.537 |
LIG_LIR_Apic_2 | 382 | 388 | PF02991 | 0.343 |
LIG_LIR_Apic_2 | 51 | 57 | PF02991 | 0.451 |
LIG_LIR_Gen_1 | 121 | 126 | PF02991 | 0.488 |
LIG_LIR_Gen_1 | 159 | 168 | PF02991 | 0.434 |
LIG_LIR_Gen_1 | 169 | 179 | PF02991 | 0.452 |
LIG_LIR_Gen_1 | 291 | 301 | PF02991 | 0.492 |
LIG_LIR_Gen_1 | 36 | 45 | PF02991 | 0.537 |
LIG_LIR_Gen_1 | 390 | 399 | PF02991 | 0.389 |
LIG_LIR_Gen_1 | 645 | 652 | PF02991 | 0.678 |
LIG_LIR_Nem_3 | 121 | 125 | PF02991 | 0.516 |
LIG_LIR_Nem_3 | 159 | 165 | PF02991 | 0.434 |
LIG_LIR_Nem_3 | 169 | 174 | PF02991 | 0.452 |
LIG_LIR_Nem_3 | 253 | 258 | PF02991 | 0.475 |
LIG_LIR_Nem_3 | 291 | 297 | PF02991 | 0.492 |
LIG_LIR_Nem_3 | 36 | 41 | PF02991 | 0.537 |
LIG_LIR_Nem_3 | 390 | 396 | PF02991 | 0.360 |
LIG_LIR_Nem_3 | 539 | 545 | PF02991 | 0.305 |
LIG_LIR_Nem_3 | 565 | 570 | PF02991 | 0.502 |
LIG_NRBOX | 152 | 158 | PF00104 | 0.462 |
LIG_NRBOX | 58 | 64 | PF00104 | 0.512 |
LIG_NRBOX | 638 | 644 | PF00104 | 0.657 |
LIG_NRP_CendR_1 | 688 | 691 | PF00754 | 0.643 |
LIG_PCNA_yPIPBox_3 | 630 | 643 | PF02747 | 0.549 |
LIG_Rb_LxCxE_1 | 51 | 73 | PF01857 | 0.476 |
LIG_SH2_CRK | 162 | 166 | PF00017 | 0.435 |
LIG_SH2_CRK | 357 | 361 | PF00017 | 0.462 |
LIG_SH2_CRK | 38 | 42 | PF00017 | 0.516 |
LIG_SH2_SRC | 357 | 360 | PF00017 | 0.451 |
LIG_SH2_SRC | 54 | 57 | PF00017 | 0.511 |
LIG_SH2_STAP1 | 154 | 158 | PF00017 | 0.451 |
LIG_SH2_STAP1 | 162 | 166 | PF00017 | 0.451 |
LIG_SH2_STAP1 | 294 | 298 | PF00017 | 0.396 |
LIG_SH2_STAP1 | 38 | 42 | PF00017 | 0.474 |
LIG_SH2_STAT3 | 120 | 123 | PF00017 | 0.451 |
LIG_SH2_STAT3 | 526 | 529 | PF00017 | 0.319 |
LIG_SH2_STAT5 | 393 | 396 | PF00017 | 0.360 |
LIG_SH2_STAT5 | 526 | 529 | PF00017 | 0.319 |
LIG_SH2_STAT5 | 54 | 57 | PF00017 | 0.450 |
LIG_SH2_STAT5 | 648 | 651 | PF00017 | 0.530 |
LIG_SH3_1 | 357 | 363 | PF00018 | 0.462 |
LIG_SH3_2 | 246 | 251 | PF14604 | 0.326 |
LIG_SH3_3 | 144 | 150 | PF00018 | 0.512 |
LIG_SH3_3 | 243 | 249 | PF00018 | 0.455 |
LIG_SH3_3 | 357 | 363 | PF00018 | 0.462 |
LIG_SUMO_SIM_anti_2 | 172 | 178 | PF11976 | 0.462 |
LIG_SUMO_SIM_par_1 | 172 | 178 | PF11976 | 0.462 |
LIG_SUMO_SIM_par_1 | 225 | 230 | PF11976 | 0.445 |
LIG_SUMO_SIM_par_1 | 531 | 537 | PF11976 | 0.319 |
LIG_SUMO_SIM_par_1 | 80 | 86 | PF11976 | 0.473 |
LIG_TRAF2_1 | 562 | 565 | PF00917 | 0.437 |
LIG_TRAF2_1 | 585 | 588 | PF00917 | 0.629 |
LIG_TYR_ITSM | 34 | 41 | PF00017 | 0.537 |
LIG_UBA3_1 | 173 | 181 | PF00899 | 0.476 |
LIG_UBA3_1 | 194 | 200 | PF00899 | 0.429 |
LIG_UBA3_1 | 622 | 627 | PF00899 | 0.681 |
LIG_WRC_WIRS_1 | 393 | 398 | PF05994 | 0.264 |
LIG_WRC_WIRS_1 | 512 | 517 | PF05994 | 0.303 |
MOD_CDK_SPxK_1 | 146 | 152 | PF00069 | 0.451 |
MOD_CK1_1 | 235 | 241 | PF00069 | 0.512 |
MOD_CK1_1 | 379 | 385 | PF00069 | 0.494 |
MOD_CK1_1 | 433 | 439 | PF00069 | 0.493 |
MOD_CK1_1 | 48 | 54 | PF00069 | 0.445 |
MOD_CK1_1 | 628 | 634 | PF00069 | 0.673 |
MOD_CK1_1 | 674 | 680 | PF00069 | 0.633 |
MOD_CK1_1 | 7 | 13 | PF00069 | 0.434 |
MOD_CK2_1 | 166 | 172 | PF00069 | 0.476 |
MOD_CK2_1 | 2 | 8 | PF00069 | 0.426 |
MOD_CK2_1 | 449 | 455 | PF00069 | 0.591 |
MOD_CK2_1 | 623 | 629 | PF00069 | 0.532 |
MOD_CK2_1 | 674 | 680 | PF00069 | 0.527 |
MOD_GlcNHglycan | 207 | 210 | PF01048 | 0.251 |
MOD_GlcNHglycan | 237 | 240 | PF01048 | 0.527 |
MOD_GlcNHglycan | 378 | 381 | PF01048 | 0.542 |
MOD_GlcNHglycan | 47 | 50 | PF01048 | 0.243 |
MOD_GlcNHglycan | 590 | 593 | PF01048 | 0.633 |
MOD_GSK3_1 | 157 | 164 | PF00069 | 0.368 |
MOD_GSK3_1 | 201 | 208 | PF00069 | 0.451 |
MOD_GSK3_1 | 336 | 343 | PF00069 | 0.509 |
MOD_GSK3_1 | 426 | 433 | PF00069 | 0.481 |
MOD_GSK3_1 | 583 | 590 | PF00069 | 0.673 |
MOD_GSK3_1 | 671 | 678 | PF00069 | 0.538 |
MOD_N-GLC_1 | 109 | 114 | PF02516 | 0.327 |
MOD_N-GLC_1 | 166 | 171 | PF02516 | 0.190 |
MOD_NEK2_1 | 156 | 161 | PF00069 | 0.451 |
MOD_NEK2_1 | 166 | 171 | PF00069 | 0.451 |
MOD_NEK2_1 | 18 | 23 | PF00069 | 0.502 |
MOD_NEK2_1 | 207 | 212 | PF00069 | 0.451 |
MOD_NEK2_1 | 271 | 276 | PF00069 | 0.441 |
MOD_NEK2_1 | 33 | 38 | PF00069 | 0.512 |
MOD_NEK2_1 | 430 | 435 | PF00069 | 0.399 |
MOD_NEK2_1 | 623 | 628 | PF00069 | 0.605 |
MOD_NEK2_1 | 643 | 648 | PF00069 | 0.352 |
MOD_PIKK_1 | 166 | 172 | PF00454 | 0.556 |
MOD_PIKK_1 | 207 | 213 | PF00454 | 0.451 |
MOD_PIKK_1 | 256 | 262 | PF00454 | 0.335 |
MOD_PKA_2 | 201 | 207 | PF00069 | 0.451 |
MOD_PKA_2 | 250 | 256 | PF00069 | 0.431 |
MOD_PKA_2 | 410 | 416 | PF00069 | 0.468 |
MOD_PKA_2 | 426 | 432 | PF00069 | 0.472 |
MOD_PKA_2 | 473 | 479 | PF00069 | 0.578 |
MOD_PKA_2 | 583 | 589 | PF00069 | 0.550 |
MOD_Plk_1 | 166 | 172 | PF00069 | 0.395 |
MOD_Plk_1 | 671 | 677 | PF00069 | 0.620 |
MOD_Plk_2-3 | 410 | 416 | PF00069 | 0.518 |
MOD_Plk_4 | 161 | 167 | PF00069 | 0.373 |
MOD_Plk_4 | 296 | 302 | PF00069 | 0.472 |
MOD_Plk_4 | 362 | 368 | PF00069 | 0.451 |
MOD_Plk_4 | 379 | 385 | PF00069 | 0.374 |
MOD_Plk_4 | 487 | 493 | PF00069 | 0.409 |
MOD_Plk_4 | 511 | 517 | PF00069 | 0.303 |
MOD_Plk_4 | 643 | 649 | PF00069 | 0.550 |
MOD_Plk_4 | 671 | 677 | PF00069 | 0.601 |
MOD_ProDKin_1 | 109 | 115 | PF00069 | 0.556 |
MOD_ProDKin_1 | 146 | 152 | PF00069 | 0.451 |
MOD_ProDKin_1 | 485 | 491 | PF00069 | 0.397 |
MOD_SUMO_for_1 | 316 | 319 | PF00179 | 0.462 |
MOD_SUMO_for_1 | 649 | 652 | PF00179 | 0.530 |
MOD_SUMO_rev_2 | 274 | 281 | PF00179 | 0.455 |
MOD_SUMO_rev_2 | 674 | 684 | PF00179 | 0.557 |
MOD_SUMO_rev_2 | 69 | 77 | PF00179 | 0.465 |
TRG_DiLeu_BaEn_1 | 178 | 183 | PF01217 | 0.451 |
TRG_DiLeu_BaEn_1 | 618 | 623 | PF01217 | 0.651 |
TRG_DiLeu_BaEn_1 | 638 | 643 | PF01217 | 0.350 |
TRG_DiLeu_BaEn_2 | 380 | 386 | PF01217 | 0.318 |
TRG_DiLeu_BaEn_2 | 391 | 397 | PF01217 | 0.403 |
TRG_DiLeu_BaEn_3 | 565 | 571 | PF01217 | 0.440 |
TRG_ENDOCYTIC_2 | 122 | 125 | PF00928 | 0.562 |
TRG_ENDOCYTIC_2 | 154 | 157 | PF00928 | 0.451 |
TRG_ENDOCYTIC_2 | 162 | 165 | PF00928 | 0.451 |
TRG_ENDOCYTIC_2 | 294 | 297 | PF00928 | 0.482 |
TRG_ENDOCYTIC_2 | 38 | 41 | PF00928 | 0.488 |
TRG_ENDOCYTIC_2 | 393 | 396 | PF00928 | 0.360 |
TRG_ENDOCYTIC_2 | 648 | 651 | PF00928 | 0.676 |
TRG_ER_diArg_1 | 494 | 496 | PF00400 | 0.434 |
TRG_ER_diArg_1 | 555 | 558 | PF00400 | 0.616 |
TRG_ER_diArg_1 | 63 | 66 | PF00400 | 0.537 |
TRG_NES_CRM1_1 | 390 | 400 | PF08389 | 0.391 |
TRG_NES_CRM1_1 | 552 | 565 | PF08389 | 0.432 |
TRG_NES_CRM1_1 | 615 | 629 | PF08389 | 0.681 |
TRG_NLS_Bipartite_1 | 320 | 334 | PF00514 | 0.479 |
TRG_NLS_MonoExtC_3 | 606 | 612 | PF00514 | 0.588 |
TRG_NLS_MonoExtN_4 | 604 | 611 | PF00514 | 0.632 |
TRG_Pf-PMV_PEXEL_1 | 213 | 217 | PF00026 | 0.260 |
TRG_Pf-PMV_PEXEL_1 | 525 | 529 | PF00026 | 0.303 |
TRG_Pf-PMV_PEXEL_1 | 87 | 91 | PF00026 | 0.251 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4X4 | Leptomonas seymouri | 83% | 99% |
A0A0S4IX79 | Bodo saltans | 56% | 95% |
A0A0S4JPF4 | Bodo saltans | 23% | 100% |
A0A1X0P5E1 | Trypanosomatidae | 66% | 97% |
A0A3Q8ID91 | Leishmania donovani | 33% | 100% |
A0A3Q8IE53 | Leishmania donovani | 29% | 88% |
A0A3S5H6T7 | Leishmania donovani | 27% | 100% |
A0A3S7WQ33 | Leishmania donovani | 30% | 100% |
A0A3S7X5R1 | Leishmania donovani | 31% | 89% |
A0A3S7X9W0 | Leishmania donovani | 91% | 100% |
A0A3S7XAT8 | Leishmania donovani | 35% | 100% |
A0A422NKE3 | Trypanosoma rangeli | 65% | 95% |
A1A4H6 | Bos taurus | 29% | 90% |
A4H7Y3 | Leishmania braziliensis | 27% | 100% |
A4HGR1 | Leishmania braziliensis | 33% | 100% |
A4HP49 | Leishmania braziliensis | 34% | 100% |
A4HT33 | Leishmania infantum | 30% | 100% |
A4HWB0 | Leishmania infantum | 27% | 100% |
A4HZF8 | Leishmania infantum | 27% | 100% |
A4I2K1 | Leishmania infantum | 29% | 88% |
A4I3T6 | Leishmania infantum | 33% | 100% |
A4I846 | Leishmania infantum | 31% | 89% |
A4IBU1 | Leishmania infantum | 91% | 100% |
A4IDF6 | Leishmania infantum | 35% | 100% |
A4QYM6 | Magnaporthe oryzae (strain 70-15 / ATCC MYA-4617 / FGSC 8958) | 28% | 87% |
A4R8G3 | Magnaporthe oryzae (strain 70-15 / ATCC MYA-4617 / FGSC 8958) | 29% | 100% |
A5DAR2 | Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324) | 26% | 93% |
A6R918 | Ajellomyces capsulatus (strain NAm1 / WU24) | 35% | 100% |
C9ZYS3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 68% | 90% |
E9AFM8 | Leishmania major | 89% | 100% |
E9ASV7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 35% | 100% |
E9B028 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 32% | 100% |
E9B6T1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
O60173 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 27% | 97% |
P0CR08 | Cryptococcus neoformans var. neoformans serotype D (strain JEC21 / ATCC MYA-565) | 31% | 92% |
P0CR09 | Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) | 31% | 92% |
Q09903 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 28% | 92% |
Q0DLB9 | Oryza sativa subsp. japonica | 28% | 100% |
Q4Q1K8 | Leishmania major | 30% | 100% |
Q4Q1N9 | Leishmania major | 35% | 100% |
Q4Q858 | Leishmania major | 33% | 100% |
Q59S50 | Candida albicans (strain SC5314 / ATCC MYA-2876) | 27% | 95% |
Q6CK32 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) | 25% | 93% |
Q6FIL3 | Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) | 32% | 100% |
Q6NZQ2 | Mus musculus | 29% | 100% |
Q750Q4 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | 29% | 100% |
Q86B47 | Drosophila melanogaster | 30% | 71% |
Q9H8H2 | Homo sapiens | 28% | 81% |
V5BG99 | Trypanosoma cruzi | 27% | 84% |
V5DUK0 | Trypanosoma cruzi | 64% | 90% |